Cargando…

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review

INTRODUCTION: Etanercept (ETN), a highly effective biological agent for the treatment of psoriasis (PSO) and psoriatic arthritis (PsA), is widely used in Spain. However, evidence of its economic impact is limited, indicating the need for a systematic review of the economic assessments conducted on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puig, Lluís, Fernández-Freire, Lourdes Rodríguez, Burgos-Pol, Ramón, Gomez, Ismael, Peral, Carmen, Gomez, Susana, Rebollo Laserna, Francisco José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704195/ https://www.ncbi.nlm.nih.gov/pubmed/31062222 http://dx.doi.org/10.1007/s13555-019-0301-6

Ejemplares similares

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch, Dario, et al.
Publicado: (2014)

The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review
por: Cañete, Juan D., et al.
Publicado: (2020)

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment
por: Boggs, Robert L, et al.
Publicado: (2014)

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
por: Strand, Vibeke, et al.
Publicado: (2012)

Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes
por: Pfeifer, Emily C., et al.
Publicado: (2017)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis
por: Bukiej, Aleksandra
Publicado: (2020)

Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy
por: Wu, Keng-Yi, et al.
Publicado: (2015)

Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis
por: Ruano, Juan, et al.
Publicado: (2013)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain
por: Puig, L., et al.
Publicado: (2017)

Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis
por: Feldman, Steven R., et al.
Publicado: (2015)

Mitogen-activated kinases in psoriatic arthritis: differences in activation and distinct regulation by etanercept therapy
por: Lories, RJU, et al.
Publicado: (2005)

Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020)

Sleep disorders in patients with psoriatic arthritis and psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2020)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Qi, Fei, et al.
Publicado: (2021)

The burden of psoriasis in patients with early psoriatic arthritis
por: Kasiem, Fazira R, et al.
Publicado: (2021)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
por: Panda, Saumya
Publicado: (2022)

Association of Behçet disease with psoriasis and psoriatic arthritis
por: Hahn, Hyung Jin, et al.
Publicado: (2021)

Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire
por: You, Hyang-Suk, et al.
Publicado: (2015)

Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
por: Strohal, R, et al.
Publicado: (2014)

Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
por: Butbul Aviel, Yonatan, et al.
Publicado: (2013)

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis
por: Loft, Nikolai Dyrberg, et al.
Publicado: (2018)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
por: Schweikert, Bernd, et al.
Publicado: (2020)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2020)

The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
por: Azanza, José Ramón, et al.
Publicado: (2020)

Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)
por: Tveit, K.S., et al.
Publicado: (2018)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
por: Pennington, Stephen R., et al.
Publicado: (2021)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Risk factors and predictors of psoriatic arthritis in patients with psoriasis
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2013)

Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
por: Kurizky, Patricia Shu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mjmrmgi1r6lilgjkigbpi5boam